Pharmaceutical companies will suffer an estimated $65B drop in sales by 2019 due to the patent...
In the suit, Acura alleges that a generic of Acura's AVERSION® oxycodone product, previously...
Sandoz has completed its $1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.
United Therapeutics Corporation today announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Sandoz Inc. (Sandoz) for infringement of U.S. Patent Nos. 5,153,222, 6,765,117 and 7,999,007 relating to United Therapeutics' product Remodulin (treprostinil) injection (Remodulin).
TRENTON, New Jersey (AP) — A severe shortage of a childhood cancer drug should ease before hospitals run out of it in a couple weeks, a top federal regulator said Tuesday. But the companies that make the drug are giving few details about how they will find a long-term solution to end the problem.
Momenta Pharmaceuticals Inc. said Monday that its partner Sandoz's launch of a generic version of the blood thinner Lovenox will trigger royalty payments when Sandoz starts selling the drug during the fourth quarter.
Sandoz Inc.has initiated a voluntary recall in the US of all 50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate Injection, USP product ("methotrexate") to the consumer/user level.
Momenta Pharmaceuticals today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox(R).
NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Tuesday it plans to expand a suit against Momenta Pharmaceuticals Inc. and Sandoz Inc., which are hoping to market a generic version of Teva's multiple sclerosis drug Copaxone.
NEW YORK (AP) — Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.
BRUSSELS (AP) — Sanofi-Aventis SA, Novartis AG and Ratiopharm International GmbH said Wednesday that EU regulators had carried out surprise raids at their French offices as part of an antitrust probe.
AMRI has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr. Reddy’s Laboratories, Ltd., Dr. Reddy’s Laboratories, Inc. and Sandoz, Inc. (“the defendants”) for infringement of AMRI’s U.S. Patent Number 7,390,906.
NEW YORK (AP) — Novartis AG's Sandoz unit has launched a generic version of the drug Prograf, which is used to help prevent rejection of a transplanted kidney or liver. The drug, also called tracrolimus, suppresses the immune system to keep it from attacking the transplanted organ.
NEW YORK (AP) — Shares of Medicis Pharmaceutical Corp. advanced Tuesday after the company said regulators approved two new doses of its top drug, the acne treatment Solodyn. Medicis said the Food and Drug Administration approved 65 mg and 115 mg doses of acne drug Solodyn.
FRANKFORT, Ky. (AP) — Kentucky Attorney General Jack Conway says a Franklin County jury has handed down a $16 million judgment against Sandoz, the generic-drugs division of pharmaceutical giant Novartis.
ALEXANDER G. HIGGINS Associated Press Writer GENEVA (AP) — Pharmaceuticals maker Novartis AG reported Thursday a 14 percent decline in first-quarter net profit in part due to shifts in currency values as well as the cost of financing its takeover of the Alcon eye care company.
By LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) — Pfizer Inc. will begin selling dozens more generic drugs in the U.S. and Europe through new deals with an Indian generic company, part of a recent trend of brand-name drugmakers expanding in a growing generics market.
By BOB JOHNSON Associated Press Writer MONTGOMERY, Alabama (AP) — Jurors ordered the German-based pharmaceutical company Sandoz Inc. on Tuesday to pay Alabama $78.4 million for causing government insurance program to pay too much for prescription drugs from 1991 to 2005.
By BOB JOHNSON Associated Press Writer MONTGOMERY, Ala. (AP) — An attorney for the state of Alabama asked a jury Monday to order generic drug manufacturer Sandoz to pay as much as $170 million because the state claims its Medicaid program paid too much for prescription drugs for more than a decade.
MONTGOMERY, Ala. (AP) — Jurors are to resume deliberations in the trial of the state of Alabama's lawsuit against generic drug manufacturer Sandoz. Jurors deliberated for about two and a half hours Monday without reaching a verdict. They will resume deliberations at 9 a.m.
By BOB JOHNSON Associated Press Writer MONTGOMERY, Ala. (AP) — An attorney for the state of Alabama told jurors Tuesday that generic drug producer Sandoz Inc. set out to cheat the state's Medicaid program with inflated prices, a claim the Germany-based firm disputed as trial on the issue began.
MONTGOMERY, Ala. (AP) — Jury selection is set to begin in the trial of the state of Alabama's lawsuit against generic drug producer Sandoz Inc. The jury for the trial is to be selected Monday in Montgomery County Circuit Judge Charles Price's courtroom.
BASEL, Switzerland (AP) — Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, helped by steady sales growth and the absence of the restructuring charges that hindered the previous year's results. The company said net income rose to $1.
NEW YORK (AP) - Johnson & Johnson's PriCara division has recalled two lots of the pain patch Duragesic, or fentanyl, because of tears in the products that could expose users directly to the product's effective gel, causing an overdose. In February, the New Brunswick, N.J.
By BOB JOHNSON Associated Press Writer MONTGOMERY, Ala. (AP) - Alabama will receive nearly $35 million from settlements of 10 lawsuits accusing prescription drug companies of overcharging the state's Medicaid program. Details of the settlements were revealed Tuesday by Attorney General Troy King.
Global prescription sales growth of generics drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, according to a new report by IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries.
Addressing the Challenges Contract Manufacturing Organizations are Facing: New Clarification Technology Provides Disposable, Flexible and Scalable SolutionNovember 3, 2008 8:13 am | Articles | Comments
As the market for biopharmaceutical products rapidly expands, pharmaceutical and biotechnology companies are increasingly turning to Contract Manufacturing Organizations (CMOs) to help streamline their processes.
- Page 1